Biotech Portfolio Companies

10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.

23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California.

African genomics research company advancing precision medicine through genetic research focused on African populations.

A San Diego biotech company using AI to accelerate drug discovery and development processes.

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics.

Spanish biopharmaceutical company developing innovative treatments for oncology and other therapeutic areas.

Actelion Pharmaceuticals Ltd. is a pharmaceuticals and biotechnology company established in December 1997, headquartered in Allschwil near Basel, Switzerland.

Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Develops soft, flexible neural interfaces and implantable brain-computer interface technology.

Early-stage company potentially focused on reproductive health or maternal care technology applications.

Cloud-based life sciences R&D platform providing laboratory information management and data analysis tools for biotech and pharma companies.

Boston-based biotech company developing analytics and data solutions for the life sciences industry.

Cambridge-based biotech company developing advanced analytics solutions for life sciences applications.

Company with potential biotechnology focus, though specific business activities and market focus remain undisclosed.

A Cambridge-based biotech company developing biotechnology solutions for biodefense and biosecurity applications.

A Boston biotech company focused on biological flow systems and dynamics technologies, with $32M in Series A funding.

A San Diego biotech company focused on biological genesis and creation processes, backed by $42M in Series A funding.

BioNTech SE ( bee-ON-tek; or bye-ON-tek short for Biopharmaceutical New Technologies) is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.

An early-stage Cambridge biotech company serving as a nexus in the biopharmaceutical industry with $2.8M pre-seed funding.

A Basel-based regenerative medicine company with $150M in Series C funding, developing advanced regenerative therapies and technologies.

Biotechnology company developing gene therapies for severe genetic diseases and cancer using advanced gene editing technologies.

Precision medicine company developing targeted therapies for cancer and rare diseases using genomics-based drug discovery.

Biotechnology company using AI to discover bioactive compounds in plants for developing targeted nutrition and health products.

Alphabet's research and development biotech company focused on aging and longevity research.

Carmat develops artificial heart devices designed to replace the function of a failing heart in patients with end-stage heart failure.

AI-driven drug discovery platform that uses machine learning to accelerate pharmaceutical research and development.

Biotechnology company that produces animal proteins using fermentation technology without animals.

Biotechnology company developing innovative male contraceptive solutions including non-hormonal birth control methods.

Cradle Bio B.V. (doing business as Cradle) is a Dutch–Swiss biotechnology company that develops software using machine learning for protein engineering.

Biotechnology company developing enzymatic DNA synthesis technology to enable on-demand, decentralized production of synthetic DNA for research and therapeutics.

Biopharmaceutical company focused on developing and commercializing novel therapeutics for dermatological conditions.

Editas Medicine, Inc., (formerly Gengine, Inc.), is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology.

AI-driven drug discovery company that mines natural products and traditional medicines to develop new pharmaceuticals.

EnvedaBiotech, North America operates in the biotechnology sector focusing on life sciences and pharmaceutical development.

Clinical-stage biotechnology company developing oral therapies that modulate the gut microbiome to treat inflammatory diseases.

Biopharmaceutical company focused on developing therapies for fibrotic diseases, anemia, and cancer through innovative drug discovery.

Biotechnology company developing cancer immunotherapies targeting the CD47 pathway to enhance immune system recognition of cancer cells.

Foundation Medicine, Inc. is an American company based in Boston, Massachusetts, which develops, manufactures, and sells genomic profiling assays based on next-generation sequencing technology for solid tumors, hematologic malignancies, and sarcomas.

Clinical-stage biopharmaceutical company developing small molecule drugs for genetically defined diseases using gene modulation approach.

Norwegian biotech company developing blood-brain barrier technology to improve drug delivery for treating neurological diseases.

Biotechnology company producing animal-free collagen and proteins through precision fermentation for cosmetics and consumer products.

Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California.

Generate:Biomedicines is a biotechnology company founded in 2018 and headquartered in Somerville, Massachusetts.

French biopharmaceutical company developing therapeutic and diagnostic solutions for metabolic and liver diseases, including NASH.

Gilgamesh Pharmaceuticals is a pharmaceutical company that is developing psychedelic and related drugs as medicines.

Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT, headed by Jason Kelly.

GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms.

Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California.

A biotechnology or healthcare company with limited publicly available information.

AI-driven drug discovery company focused on finding treatments for rare diseases using machine learning.

Population genomics company providing DNA testing and genetic insights for consumers and healthcare providers.

Biotech accelerator and venture capital firm that invests in early-stage life sciences and biotechnology startups.

Biotechnology company developing protein engineering and synthetic biology platforms for drug discovery and development.

Juno Therapeutics, Inc. was an American biopharmaceutical company founded in 2013 through a collaboration of the Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and pediatrics partner Seattle Children's Research Institute.

A biotechnology company developing cancer immunotherapies using CRISPR-based functional genomics to identify novel drug targets.

A biopharmaceutical company focused on developing and commercializing therapies for rare and underserved diseases, particularly in ophthalmology.

A clinical-stage biopharmaceutical company focused on developing novel therapies for psychiatric and neurological conditions.

Clinical-stage biopharmaceutical company developing CAR-T cell therapies for cancer treatment, with lead product cilta-cel for multiple myeloma.

Clinical-stage biopharmaceutical company developing treatments for rare endocrine diseases and hormonal disorders, ceased operations in 2021.

Biopharmaceutical company developing treatments for rare neurological diseases and CNS disorders.

Moderna, Inc. ( mə-DUR-nə) is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines.

Develops AI models for analyzing biological systems across multiple scales, from molecular to organism levels.

Swedish biotech company producing sustainable protein alternatives from fungi and food waste through fermentation.

Holding company and innovation ecosystem encompassing various technology ventures across healthcare, media, and AI.

Genetic testing and diagnostics company specializing in cell-free DNA testing for women's health, oncology, and organ health.

A Cambridge-based biotech company developing neurological therapeutics and treatments.

A company with limited publicly available information about its operations and focus area.

A therapeutics company focused on pharmaceutical or medical technology development with limited public information available.

Quantum technology company that has been acquired, operating in the quantum computing sector.

A clinical-stage biopharmaceutical company developing precision medicines using targeted protein degradation technology for cancer and inflammatory diseases.

Spanish biopharmaceutical company developing epigenetic therapies for cancer and CNS diseases using histone deacetylase and lysine demethylase inhibitors.

Owkin is a French-American artificial intelligence and biotech company that aims to identify new treatments, optimize clinical trials and develop AI diagnostics.

Paradromics Inc. is an American brain–computer interface (BCI) company headquartered in Austin, Texas with a second office located in Oakland, California.

Biotechnology company developing organoid technology for disease modeling and drug discovery applications.

Biopharmaceutical company developing novel antibiotics to treat antibiotic-resistant bacterial infections.

Clinical-stage biopharmaceutical company developing oral antiviral therapeutics for infectious diseases.

Portola Pharmaceuticals is an American clinical stage biotechnology company that researches, develops, and commercializes drugs.

Biotechnology accelerator program that supports early-stage biotech startups with funding, mentorship, and resources.

Clinical-stage precision medicine company using computational approaches to develop protein motion-based therapies for cancer.

Biotechnology company developing genetic medicines using engineered anellovectors for safer gene therapy delivery.

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies.

Clinical-stage biotech developing engineered cells as medicines to treat diseases through cell therapy platforms.

Shiok Meats develops lab-grown seafood products, specializing in cultivated shrimp, crab, and lobster through cellular agriculture.

Biotechnology company producing industrial chemicals through engineered biology and sustainable manufacturing processes.

Japanese biotech company creating synthetic spider silk and other biomaterials through fermentation technology for sustainable textile and material applications.

Clinical-stage biopharmaceutical company developing treatments for rare diseases and cancer.

Biotech company that developed cancer therapeutics targeting cancer stem cells before being acquired by AbbVie.

Biotechnology company developing innovative solutions in the life sciences sector.

Biotechnology company developing innovative therapeutics and drug discovery solutions.

Cloud-based platform that automates and optimizes laboratory experiments for biotechnology and pharmaceutical research.

Biotechnology company providing CRISPR gene editing tools, reagents, and services for research and therapeutic development.

Biopharmaceutical company developing engineered protein therapeutics for cancer using expanded genetic code technology.

Clinical-stage biotech developing cancer treatments by controlling gene expression using proprietary gene control platforms.

Tango Therapeutics develops precision oncology medicines using synthetic lethality approaches to target cancer vulnerabilities created by tumor suppressor gene loss.

Gene writing company developing a new class of genetic medicines that can write therapeutic messages into the genome to treat or cure diseases.

Biotech company developing scalable cell therapy manufacturing technologies using innovative 3D cell culture and microcarrier systems.

Precision oncology company developing targeted therapies for patients with cancer driven by specific genetic alterations.

Biotechnology company developing therapeutics to halt, slow, or reverse diseases of aging by targeting senescent cells.

Genomic diagnostics company that develops molecular tests to help physicians make treatment decisions for patients with thyroid, lung, and breast diseases.

Biomanufacturing company using machine learning and automation to engineer microbes for producing materials.